ProSomnus Sleep Technologies

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, ProSomnus Sleep Technologies sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting upper quartile by trial count

ProSomnus Sleep Technologies: 3 sponsored US clinical trials, 1 recruiting.

ProSomnus Sleep Technologies sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Obstructive Sleep Apnea, with 2 trials.

Upper-quartile sponsor footprint

ProSomnus Sleep Technologies sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the ProSomnus Sleep Technologies pipeline

1 recruiting of 3 indexed (33% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Obstructive Sleep Apnea (2 trials), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

ProSomnus Sleep Technologies: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

ProSomnus Sleep Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share ProSomnus Sleep Technologies10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
ProSomnus Sleep Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

ProSomnus Sleep Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

What to do with this ProSomnus Sleep Technologies page

3 registered trials is a research-attention snapshot, not an endorsement of ProSomnus Sleep Technologies or any single study.

  • 1 of ProSomnus Sleep Technologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obstructive Sleep Apnea is the condition ProSomnus Sleep Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obstructive Sleep Apnea trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

ProSomnus Sleep Technologies pipeline card: 3 registered trials from official public datasets.Report a data error.